Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference27 articles.
1. Cancer IAfRo (2020) Cancer IAfRo: GLOBOCAN 2020: estimated cancer incidence, mortality, and prevalence worldwide in 2020. In Website
2. Kasi PM, Hubbard JM, Grothey A (2015) Selection of biologics for patients with metastatic colorectal cancer: the role of predictive markers. Expert Rev Gastroenterol Hepatol 9:273–276
3. Roche Registration Limited (2009) Avastin (bevacizumab) summary of product characteristics (last update 10/19/2016). https://www.ema.europa.eu/en/documents/product-information/avastin-epar-product-information_en.pdf Accessed 12 Dec 2022.
4. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335–2342
5. Giantonio BJ, Catalano PJ, Meropol NJ, O’Dwyer PJ, Mitchell EP, Alberts SR, Schwartz MA, Benson AB III (2007) Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25:1539–1544
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献